To hear about similar clinical trials, please enter your email below
Trial Title:
Differentiation of Tubular Adenoma and Colonic Innominate Groove Under EC Endoscopy
NCT ID:
NCT06076369
Condition:
Endocytoscopy
Conditions: Official terms:
Adenoma
Conditions: Keywords:
tubular adenoma
IIIL duct opening
colonic innominate groove
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Procedure
Intervention name:
The tubular adenoma group
Description:
Biopsy or removal of polyps for pathological examination. Collect baseline data such as
gender, age, BMI, etc. If the pathology confirms a pure tubular adenoma, the observed
object will be included in the group for final comparative analysis.
Arm group label:
The tubular adenoma group
Other name:
the colonic innominate groove group
Summary:
This study is to analyze the characteristics of the IIIL opening of the duct in tubular
adenoma and the colonic innominate groove under EC endoscopy, in order to improve the
ability to tell lesions and the colonic innominate groove under EC endoscopy
(Endocytoscopy).
Detailed description:
This is a prospective cohort study. The recruitment time for all participants will be 4
months. The tubular adenoma group and the colonic innominate groove group will be paired
in a 1:2 ratio, with 32 lesions of tubular adenoma and 64 adjacent innominate groove. It
is expected that there will be 32 cases and a total of 96 observation subjects. Analyze
and compare the characteristics of the opening of the IIIL duct in tubular adenomas and
the colonic innominate groove under EC endoscopy, in order to summarize and differentiate
them.
Criteria for eligibility:
Study pop:
Cases of colorectal polyps discovered in our hospital and undergoing EC endoscopic
examination.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Cases of colorectal polyps discovered in our hospital and undergoing EC endoscopic
examination.
Exclusion Criteria:
- 1.Suffering from hereditary polyposis or inflammatory bowel disease, severe
intestinal inflammation, or difficulty recognizing normal intestinal mucosa;
2. History of methylene blue allergy;
3. Patients who have participated or are currently participating in other clinical
trials within the first 4 weeks of enrollment;
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
the First Hospital of Jilin University
Address:
City:
Chang chun
Zip:
130021
Country:
China
Status:
Recruiting
Contact:
Last name:
Dong Yang, Master
Start date:
March 26, 2024
Completion date:
December 30, 2024
Lead sponsor:
Agency:
Jilin University
Agency class:
Other
Source:
Jilin University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06076369
